ANVISA registration 80134860316Valid until Jun 30, 2035IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY
ANVISA Registration Number: 80134860316GRIFOLS BRASIL LTDAMEDION GRIFOLS DIAGNOSTICS AGRisk Class III
Device names
- Technical name
- IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY
- Risk class
- Class III
PT: IMUNOHEMATOLOGIA - SOROS RAROS PARA METODOLOGIA CONVENCIONAL
Registration details
- Registration Number
- 80134860316
- Process Number
- 25351457914202475
- CNPJ
- 02513899000171
Company information
- Registration Holder
- GRIFOLS BRASIL LTDA
- Manufacturer
- MEDION GRIFOLS DIAGNOSTICS AG
- Manufacturing Country
- Switzerland
PT: SUÍÇA
Dates and status
- Publication Date
- Jun 30, 2025
- Validity
- 30/06/2035
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80134860316 and manufactured by MEDION GRIFOLS DIAGNOSTICS AG. The registration is held by GRIFOLS BRASIL LTDA with validity until Jun 30, 2035.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.